Nuritas, a global leader in peptide intelligence, today announced the appointment of Michael Halvorsen as chief commercial officer, strengthening its executive leadership team as the company accelerates the global commercialisation of its science-backed peptide ingredients discovered in nature.
The appointment follows the addition of former unilever North America president Kees Kruythoff as chair of Nuritas' board of directors in September, as the company expands the leadership and commercial capabilities to bring its breakthrough science into more everyday consumer products worldwide.
Halvorsen brings over 30 years of international commercial leadership across the food, beverage, nutrition and specialty ingredients industries, with a track record of building high-performing global teams, accelerating revenue growth and turning breakthrough technologies into commercially successful solutions. Most recently at Sweegen, he played a key role in expanding global commercial operations and helping multinational customers bring next-generation ingredient innovations to market.
The food and nutrition industry is at a turning point. Consumers increasingly expect more from the products they use every day, and brands are looking for ingredients that can deliver real, scientifically substantiated benefits.
At Nuritas, Halvorsen will lead the company's global commercial strategy, accelerating the adoption of its AI-discovered bioactive peptides food and beverage, nutrition, medical nutrition, health and wellness, sports nutrition and personal care. He will focus on developing long-term customer partnerships, expanding into key international markets and translating Nuritas' scientific innovations into sustainable revenue growth.
Founded in Ireland, Nuritas uses AI and molecular biology to discover bioactive peptides hidden in nature and develop them into clinically validated ingredients for consumer products. The company has identified more than 8 million peptides and built the world's largest library of natural peptides with known functionalities. Its growing portfolio, including PeptiStrong® and PeptiSleep™, is helping consumer brands develop products with scientifically substantiated health benefits.
Commenting on the appointment, Dr Nora Khaldi, Founder and CEO of Nuritas said: “We've built Nuritas on the belief that nature holds enormous untapped potential to improve human health. Through AI and science, we're unlocking that potential in ways that weren't possible before, but the real impact comes when these discoveries reach people through the products they use every day. Michael brings the commercial experience and global industry relationships to help us make that happen at scale, and I'm delighted to have him on board as we enter this next phase of growth.”
“The food and nutrition industry is at a turning point. Consumers increasingly expect more from the products they use every day, and brands are looking for ingredients that can deliver real, scientifically substantiated benefits,” said Michael Halvorsen, chief commercial officer of Nuritas. “Nuritas has the science, the technology and a growing portfolio of ingredients to meet that demand. The opportunity is to take this innovation further, working with global brands to bring the next generation of health-focused products to market at scale.”